arrow
R

Robert T. Schooley

university of california-san diego
H指数:63
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Experimental phage evolution results in expanded host ranges against antibiotic resistant Klebsiella pneumoniae isolates

实验性噬菌体进化导致对耐抗生素的克雷伯氏肺炎杆菌分离株的宿主范围扩大

2025-11-190
OAAI
Cysticercosis and neurocysticercosis in people from Mocuba district, Zambézia province: A Mozambican community-based study

猪囊尾蚴病和神经猪囊尾蚴病在莫库巴区赞比西亚省人群中的流行情况:一项莫桑比克社区为基础的研究

2025-05-130
OA
Pseudomonas aeruginosa ventricular assist device infections: findings from ineffective phage therapies in five cases (vol 68, e01728-23, 2024)
2025-02-130
OAAI
A User-Centered Service Model for Accelerating COVID-19 Diagnostic Innovation: The RADx-rad Dx Core Approach

Ledgerwood-Lee, M.; Hubenko, A.; Ray, P.; Theriault, Y.; Brickner, H.; Vazquez, L.F.; Schooley, R.; Carlin, A.; Clark, A.; Garretson, A.; 等. 一种加速COVID-19诊断创新的用户中心服务模型: RADx-Rad Dx核心方法. IEEE 工程与医学生物学开放期刊, 2025, 6, 472–479. [谷歌学术] [CrossRef]

2025-01-010
OA
Phage resistance in Klebsiella pneumoniae and bidirectional effects impacting antibiotic susceptibility

肺炎克雷伯菌噬菌体耐药性及双向效应对抗生素敏感性的影响

2024-06-014
PRE
Pseudomonas aeruginosa ventricular assist device infections: findings from ineffective phage therapies in five cases
2024-04-039
OA
Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights

面临威胁: 国际艾滋病协会-柳叶刀健康与人权委员会

LANCET
IF88.5
2024-04-015
PRE
A Cross Sectional Study on the Bidirectional Interactions Between Leptospirosis and HIV Infection Among Patients from Maputo Central Hospital, Mozambique
2024-02-011
OAAI
Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from Mozambique

药敏抗生素筛查显示,莫桑比克感染和未感染HIV的患者中沙门氏菌,志贺氏菌和弯曲杆菌的多重耐药性很高

2023-04-215
OAAI
1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity
2023-04-116
OAAI